SAN FRANCISCO--(BUSINESS WIRE)--Alta Partners, a life sciences venture capital firm based in San Francisco, today announced that Alison de Bord has been promoted to Director. Alison joins Alta’s other six Directors responsible for investing Alta Partners VIII. She currently represents Alta as a Director on the boards of Aegerion Pharmaceuticals, Insulet and SurgRx, and was directly involved in Alta’s investments in Esperion Therapeutics and Kerberos Proximal Solutions.
